ReviewClinical cancer research : an official journal of the American Association for Cancer Research2020

Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology.

Karen A Autio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.